Amylyx Pharmaceuticals, Inc. (AMLX) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts AMLX Hot Sheet
Join SI Premium – FREE
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q2 EPS of ($0.46), in-line with the analyst estimate of ($0.46).
For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lightbridge (LTBR) Misses Q2 EPS by 18c
- Universal Technical Institute (UTI) Tops Q3 EPS by 2c; Offers Guidance
- FTAI Infrastructure Inc. (FIP) Misses Q2 EPS by 99c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
